Psilocybin therapy to reduce depression following a terminal diagnosis
Elizabeth Boudreau, Krissa Orlowski
JAAPA November 21, 2023 DOI: 10.1097/01.jaa.0000994952.07847.2d (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin Depression |
| Keywords | Depression economics Elixir programming language Psychotherapist Hallucinogen |
Abstract
At the time this abstract was written, Elizabeth Boudreau was a student in the Medex Northwest PA program at the University of Washington School of Medicine. Krissa Orlowski is a part-time lecturer in the Medex Northwest PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.